Thrivent Financial for Lutherans Has $14.77 Million Holdings in Veeva Systems Inc. (NYSE:VEEV)

Thrivent Financial for Lutherans trimmed its position in Veeva Systems Inc. (NYSE:VEEV) by 20.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 70,241 shares of the technology company’s stock after selling 18,213 shares during the period. Thrivent Financial for Lutherans’ holdings in Veeva Systems were worth $14,768,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cardinal Capital Management raised its stake in shares of Veeva Systems by 0.3% in the 4th quarter. Cardinal Capital Management now owns 15,727 shares of the technology company’s stock valued at $3,307,000 after buying an additional 44 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its stake in Veeva Systems by 72.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock worth $25,000 after purchasing an additional 50 shares during the period. Patriot Financial Group Insurance Agency LLC boosted its holdings in Veeva Systems by 0.7% during the fourth quarter. Patriot Financial Group Insurance Agency LLC now owns 6,975 shares of the technology company’s stock valued at $1,467,000 after purchasing an additional 51 shares in the last quarter. CHICAGO TRUST Co NA grew its stake in shares of Veeva Systems by 2.9% in the 4th quarter. CHICAGO TRUST Co NA now owns 1,880 shares of the technology company’s stock valued at $395,000 after purchasing an additional 53 shares during the period. Finally, Old North State Wealth Management LLC raised its holdings in shares of Veeva Systems by 0.4% in the 4th quarter. Old North State Wealth Management LLC now owns 15,351 shares of the technology company’s stock worth $3,228,000 after buying an additional 55 shares in the last quarter. 88.20% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

VEEV has been the topic of several recent analyst reports. Royal Bank of Canada boosted their price target on Veeva Systems from $275.00 to $285.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Bank of America increased their target price on shares of Veeva Systems from $280.00 to $290.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Piper Sandler lifted their price target on shares of Veeva Systems from $280.00 to $290.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Scotiabank upped their price objective on shares of Veeva Systems from $240.00 to $245.00 and gave the stock a “sector perform” rating in a research note on Thursday, March 6th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $270.00 target price on shares of Veeva Systems in a research note on Thursday, March 6th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Veeva Systems presently has a consensus rating of “Moderate Buy” and a consensus target price of $256.52.

Veeva Systems Stock Up 0.5 %

VEEV stock opened at $236.98 on Friday. Veeva Systems Inc. has a twelve month low of $170.25 and a twelve month high of $258.93. The company has a market cap of $38.47 billion, a P/E ratio of 58.51, a price-to-earnings-growth ratio of 1.89 and a beta of 0.88. The business’s fifty day moving average is $229.24 and its 200-day moving average is $222.17.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.